Utility of the NIH Toolbox Cognition Battery in middle to older aged adults with longstanding type 1 diabetes: The DCCT/EDIC study.

IF 3 3区 心理学 Q2 CLINICAL NEUROLOGY
Clinical Neuropsychologist Pub Date : 2024-05-01 Epub Date: 2023-10-09 DOI:10.1080/13854046.2023.2266876
Naomi S Chaytor, Victoria R Trapani, Barbara H Braffett, Luciana M Fonseca, Gayle M Lorenzi, Rose A Gubitosi-Klug, Susan Hitt, Kaleigh Farrell, Alan M Jacobson, Christopher M Ryan
{"title":"Utility of the NIH Toolbox Cognition Battery in middle to older aged adults with longstanding type 1 diabetes: The DCCT/EDIC study.","authors":"Naomi S Chaytor, Victoria R Trapani, Barbara H Braffett, Luciana M Fonseca, Gayle M Lorenzi, Rose A Gubitosi-Klug, Susan Hitt, Kaleigh Farrell, Alan M Jacobson, Christopher M Ryan","doi":"10.1080/13854046.2023.2266876","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b> Adults with type 1 diabetes (T1D) face an increased risk for cognitive decline and dementia. Diabetes-related and vascular risk factors have been linked to cognitive decline using detailed neuropsychological testing; however, it is unclear if cognitive screening batteries can detect cognitive changes associated with aging in T1D. <b>Method:</b> 1,049 participants with T1D (median age 59 years; range 43-74) from the Diabetes Control and Complications Trial (DCCT), and the follow-up Epidemiology of Diabetes Interventions and Complications (EDIC) study, completed the NIH Toolbox Cognition Battery (NIHTB-C) and Montreal Cognitive Assessment (MoCA). Neuropsychological assessments, depression, glycated hemoglobin levels (HbA1c), severe hypoglycemia, T1D complications, and vascular risk factors were assessed repeatedly over 32 years to determine associations with current NIHTB-C performance. Available cognitive data was clinically adjudicated to determine cognitive impairment status. <b>Results:</b> NIHTB-C scores had moderate associations (<i>r</i> = 0.36-0.53) with concurrently administered neuropsychological tests. In multivariate models, prior severe hypoglycemic episodes, depression symptoms, nephropathy, lower BMI, and higher HbA1c and LDL cholesterol were associated with poorer NIHTB-C Fluid Cognition Composite scores. The NIHTB-C adequately detected adjudicated cognitive impairment (Area Under the Curve = 0.86; optimal cut score ≤90). The MoCA performed similarly (Area Under the Curve = 0.83; optimal cut score ≤25). <b>Conclusions:</b> The NIHTB-C is sensitive to the cognitive effects of diabetes-related and vascular risk factors, correlated with neuropsychological testing, and accurately detects adjudicated cognitive impairment. These data support its use as a screening test in middle to older aged adults with T1D to determine if referral for detailed neuropsychological assessment is needed.</p>","PeriodicalId":55250,"journal":{"name":"Clinical Neuropsychologist","volume":" ","pages":"1007-1027"},"PeriodicalIF":3.0000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11001788/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Neuropsychologist","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1080/13854046.2023.2266876","RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/10/9 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Adults with type 1 diabetes (T1D) face an increased risk for cognitive decline and dementia. Diabetes-related and vascular risk factors have been linked to cognitive decline using detailed neuropsychological testing; however, it is unclear if cognitive screening batteries can detect cognitive changes associated with aging in T1D. Method: 1,049 participants with T1D (median age 59 years; range 43-74) from the Diabetes Control and Complications Trial (DCCT), and the follow-up Epidemiology of Diabetes Interventions and Complications (EDIC) study, completed the NIH Toolbox Cognition Battery (NIHTB-C) and Montreal Cognitive Assessment (MoCA). Neuropsychological assessments, depression, glycated hemoglobin levels (HbA1c), severe hypoglycemia, T1D complications, and vascular risk factors were assessed repeatedly over 32 years to determine associations with current NIHTB-C performance. Available cognitive data was clinically adjudicated to determine cognitive impairment status. Results: NIHTB-C scores had moderate associations (r = 0.36-0.53) with concurrently administered neuropsychological tests. In multivariate models, prior severe hypoglycemic episodes, depression symptoms, nephropathy, lower BMI, and higher HbA1c and LDL cholesterol were associated with poorer NIHTB-C Fluid Cognition Composite scores. The NIHTB-C adequately detected adjudicated cognitive impairment (Area Under the Curve = 0.86; optimal cut score ≤90). The MoCA performed similarly (Area Under the Curve = 0.83; optimal cut score ≤25). Conclusions: The NIHTB-C is sensitive to the cognitive effects of diabetes-related and vascular risk factors, correlated with neuropsychological testing, and accurately detects adjudicated cognitive impairment. These data support its use as a screening test in middle to older aged adults with T1D to determine if referral for detailed neuropsychological assessment is needed.

NIH工具箱认知电池在患有长期1型糖尿病的中老年人中的应用:DCCT/EDIC研究。
目的:患有1型糖尿病(T1D)的成年人面临认知能力下降和痴呆的风险增加。通过详细的神经心理学测试,糖尿病相关和血管风险因素与认知能力下降有关;然而,目前尚不清楚认知筛查电池是否能检测到与T1D衰老相关的认知变化。方法:1049名T1D患者(中位年龄59岁) 年;范围43-74),以及糖尿病干预和并发症流行病学(EDIC)的后续研究,完成了NIH工具箱认知电池(NIHTB-C)和蒙特利尔认知评估(MoCA)。对神经心理学评估、抑郁、糖化血红蛋白水平(HbA1c)、严重低血糖、T1D并发症和血管危险因素进行了反复评估 年来确定与当前NIHTB-C表现的相关性。对可用的认知数据进行临床裁定,以确定认知障碍状态。结果:NIHTB-C评分具有中度相关性(r = 0.36-0.53),同时进行神经心理测试。在多变量模型中,既往严重低血糖发作、抑郁症状、肾病、较低的BMI、较高的HbA1c和LDL胆固醇与较差的NIHTB-C流体认知综合评分相关。NIHTB-C充分检测到判定的认知障碍(曲线下面积=0.86;最佳切割分数≤90)。MoCA的表现类似(曲线下面积=0.83;最佳切割分数≤25)。结论:NIHTB-C对糖尿病相关因素和血管危险因素的认知影响敏感,与神经心理测试相关,并能准确检测判定的认知障碍。这些数据支持将其用作中老年T1D患者的筛查测试,以确定是否需要转诊进行详细的神经心理评估。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Neuropsychologist
Clinical Neuropsychologist 医学-临床神经学
CiteScore
8.40
自引率
12.80%
发文量
61
审稿时长
6-12 weeks
期刊介绍: The Clinical Neuropsychologist (TCN) serves as the premier forum for (1) state-of-the-art clinically-relevant scientific research, (2) in-depth professional discussions of matters germane to evidence-based practice, and (3) clinical case studies in neuropsychology. Of particular interest are papers that can make definitive statements about a given topic (thereby having implications for the standards of clinical practice) and those with the potential to expand today’s clinical frontiers. Research on all age groups, and on both clinical and normal populations, is considered.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信